Nasal sprays reduce cold duration in at-risk patients by 25%: Study
HQ Team July 18, 2024: A United Kingdom study found that Over-the-counter (OTC) nasal sprays can reduce the symptoms and duration of respiratory
HQ Team July 18, 2024: Researchers at the Virginia Commonwealth University’s School of Medicine and the Richmond VA Medical Center say that almost
Conduct disorder is a result of extensive changes in the structure of the brain and is most noticeable in the cerebral cortex, or
HQ Team July 18, 2024: In a reversal strategy in the war against cancer, researchers are now aiming to genetically cloak healthy cells
Japanese researchers have developed a non-invasive alternative to detect human papillomavirus by testing urine samples, a discovery that may transform cervical cancer screening.
British-Swedish AstraZeneca has acquired Amolyt Pharma for $1.05 billion to gain access to Lyon, France-based company’s rare disease, late-stage pipeline.
Climate change is making days longer by a few milliseconds as the ice melts in Antarctica and Greenland is causing a shift in
HQ Team July 16, 2024: A new animal study has found a new therapy that is able to boost inuslin-producing cells by 700%
HQ Team July 16, 2024: A new study by Northwestern Medicine and Brigham and Women’s Hospital researchers has identified a possible cause for
Novo Nordisk, has been denied approval for its type 1 diabetic medicine by the USFDA, according to the Danish drugmaker.